AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06442202 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Nutritional Education
Description: Nutritional education is provided via online Zoom meetings with the help of educational media in the form of PowerPoint presentations/videos before entering the intervention period. The educational material that will be provided is regarding Guidelines for Balanced Nutrition, Food Safety, and Healthy Lifestyles (stress management and sleep time). The subject's understanding of the material provided was evaluated using an online quiz platform.
Study NCT01319175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hip flexion strength training
Study NCT04461184 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet Wellness Intervention for Aging
Description: Internet technologies have emerged as a platform for performing wellness interventions that also have wide outreach. Previous studies that have used the internet for delivering health interventions have found that older adults valued this platform, used it for researching health information and social communications. Likewise, the effectiveness of delivering health-related information intended for behavior change through the internet is equal to that of print-based delivery, thereby lowering costs and expanding reach. Thus, the internet provides a unique platform for conducting interventions. The internet based wellness intervention will be a low cost method focused on older adults to help increase intrinsic motivation through autonomy, competence, and relatedness (Intrinsic Motivation) to help increase daily physical activity.
Study NCT05031468 — intervention group
Intervention type: BIOLOGICAL
Intervention: Licensed or EUA SARS-CoV-2 vaccine
Description: Several SARS-CoV-2 vaccines utilizing different platforms (e.g., mRNA, viral vector, etc.), are available under EUA (and soon to be licensed) and are being administered to individuals who are pregnant or postpartum who belong to high-risk priority groups for vaccination. Participants will receive the SARS-CoV-2 vaccine of their choice or the type that is available to them. The researchers anticipate including up to 3 vaccines, whether given as part of the primary series or additional doses, as part of this non-interventional study.
Study NCT04676633 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STP705
Description: Investigational Product
Study NCT06320327 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cannabidiol cream
Description: Group 1 will be administered the recommended quantity of CBD cream to be applied at various times throughout the study and used in a specific way instructed by the researcher (the cream is applied via massage through a standardized application method).
Study NCT06320327 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo cream
Description: Group 2 will be administered the recommended quantity of placebo cream to be applied at various times throughout the study and used in a specific way instructed by the researcher (the cream is applied via massage through a standardized application method).
Study NCT06454318 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Wellue O2 ring
Description: Wellue O2 ring wore when doing the polysomnography
Study NCT06379698 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: personalized 3D model pré-opérative education
Description: Before surgery, during a preoperative therapeutic education consultation, a personalized 3D models will be presented to the patients according to the allocated study group
Study NCT06379698 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: generic 3D model pré-opérative education
Description: Before surgery, during a preoperative therapeutic education consultation, a generic 3D models will be presented to the patients according to the allocated study group
Study NCT05282641 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 10 g of collagen hydrolysate
Description: Before breakfast, participants consume 1 sachet every day for 4 weeks. The sachet contains 10-gram collagen protein hydrolysates + 5-gram erythritol and it has to be dissolved in 250 ml of water.
Study NCT05282641 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Before breakfast, participants consume 1 sachet every day for 4 weeks. The sachet contains 5-gram erythritol (placebo) and has to be dissolved in 250 ml of water.
Study NCT05185297 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Recreational Futsal
Description: Participants will participate in 2-3 weekly one hour sessions of Recreational Futsal, during 3 months, while maintaining standard care provided by the family physician.
Study NCT04745377 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: IgG neutralising antibody titers to S1 and S2 proteins of SARS-COV-2 virus
Description: IgG neutralising antibody titers to S1 and S2 proteins of SARS-COV-2 virus
Study NCT05371145 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Carnosine
Description: Determine whether carnosine supplementation (2 g/day) for 3 months in peripheral arterial disease patients improves 6MWT ability.
Study NCT06112678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-348(6)
Description: QD, PO
Study NCT06112678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-828, D097, D337
Description: QD, PO
Study NCT05763056 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: McGrath videolaryngoscopy
Description: The McGrath video laryngoscope has a thin, disposable, clear, regularly shaped blade similar to a Macintosh blade and a large LCD display attached to the arm. It is lighter in weight and the Mc VL has a small camera at the tip, with a more compact screen and handle that can make tracheal intubation easier and faster in normal or difficult airway. The smaller volume, thinner and portrait screen helps reduce blind spots
Study NCT05763056 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: C-MAC videolaryngoscopy
Description: The Macintosh blade is attached to the handle and the light beam is passed through the blade tip into a small metal guide tube indented 40 mm. The camera cable is connected to the control unit and the optical cable is connected to the light source. The video macintosh system is installed in a small trolley for easy portability of the device. The trolley supports an 8-inch monitor mounted on a rotating arm on the patient's left side. C-MAC VL devices can create continuous video recordings or static images on a secure removable digital card. The electronic module includes 2 buttons for photo and video shooting. In addition, the image of the C-MAC VL device can be viewed on other devices or recorded via a standard video output port. 3 C-MAC VL reusable metal macintosh blades (sizes 2 to 4) can be used for adult patients. These non-disposable knives have a closed design without gaps in terms of hygiene and have beveled edges to prevent tissue damage.
Study NCT05763056 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Direct laryngoscopy
Description: During intubation with a direct laryngoscope (DL), the laryngoscope is inserted into the oral cavity from the right side of the mouth, the tongue is pushed to the left, and after advancing up to the vallecula, it hangs up and forward. In this way, the floor of the mouth and the epiglottis structure are removed from the field of view. If a straight blade laryngoscope is to be used, it is advanced so that the epiglottis remains under the blade after viewing the epiglottis (1). In DL, manipulations such as head extension, sniffing position, and compression of the cricoid cartilage may be required to facilitate visualization of the vocal folds. In 10-15% of the complications experienced during intubation with DL, there are problems related to the angle of view.
Study NCT05721690 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: UED-A Videolaryngoscopy
Description: Tracheal Intubation with UED-A videolaryngoscope
Study NCT05721690 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Glidescope Videolaryngoscopy
Description: Tracheal Intubation with Glidescope Titanium videolaryngoscope
Study NCT06271759 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fragrance inhalation
Description: Inhalation of fragranced essential oils
Study NCT04960397 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Physiological saline, i.e., 0.9% sodium chloride.
Study NCT04960397 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sing2016 M2SR H3N2
Description: Novel intranasal live attenuated influenza vaccine with a defective M2 gene which renders the virus unable to replicate and generate progeny in animals and in humans, making its infectivity self-limiting. It induces both a mucosal and cell-mediated immune response and is administered intranasally. Supplied by Flugen Inc.
Study NCT05437042 — intervention group
Intervention type: OTHER
Intervention: Medial calcaneal wedge
Description: Immediate effect of medial calcaneal wedge for static balance and weight distribution
Study NCT04912141 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: conestat alfa or placebo
Description: Conestat alfa will be dosed by body weight at 50 U/kg (maximum 4200 U) or 100 U/kg (maximum 8400 U).~Placebo will consist of normal saline (NaCl 0.9%). The interventions will be given to the patients by IV-line.
Study NCT04912141 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: conestat alfa or placebo
Description: Conestat alfa will be dosed by body weight at 50 U/kg (maximum 4200 U) or 100 U/kg (maximum 8400 U).~Placebo will consist of normal saline (NaCl 0.9%). The interventions will be given to the patients by IV-line.
Study NCT06013332 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PBF PLLA microsphere (injectable poly-L-lactic acid)
Description: Poly-L-lactic acid (PLLA) is a collagen stimulator, helps restore the deep, underlying structure of the skin to diminish facial wrinkles. PLLA microparticles are absorbable for human body, and it works with human body within the deep dermis to help revitalize collagen production and help restore human skin's inner structure and volume. PLLA can rebuilt collagen strands begin gradually helping to restore facial volume and the look of fullness to wrinkles and folds.
Study NCT06013332 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sculptra®
Description: Sculptra®
Study NCT06195124 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGL-193（low-dose）
Description: Each side of the putamen received 150 μL of RGL-193, with a unilateral dose of 1.5×10\^11 VG and a bilateral dose of 3.0×10\^11 VG.
Study NCT06195124 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGL-193（high-dose）
Description: Each side of the putamen received 200 μL of RGL-193, with a unilateral dose of 5.0×10\^11 VG and a bilateral dose of 1.0×10\^12 VG.
Study NCT05364619 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Qingre Huashi Granules combined the modified dual therapy
Description: Qingre Huashi Granules combined the modified dual therapy for 14 days
Study NCT05364619 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bismuth containing quadruple therapy
Description: Bismuth containing quadruple therapy for 14 days
Study NCT06257901 — intervention group
Intervention type: OTHER
Intervention: Interviews/Focus groups/Participatory workshops
Description: Qualitative study (no intervention delivered)
Study NCT05896917 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3D Printed Foot Orthosis
Description: 3D printed foot orthoses designed and fabricated at the Taibah University
Study NCT05896917 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Prefabricated Foot Orthosis
Description: Generic foot orthoses available commercially
Study NCT04731675 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AMB-05X
Description: AMB-05X is a fully human antibody antagonist (immunoglobulin G, type 2 \[IgG2\]) specific to the extracellular domain of human CSF1R
Study NCT04876768 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Use of different concentrations of oxygen during ERCP
Description: The endoscopic intervention will be conducted in the endoscopy suite located at UK Albert B. Chandler Hospital in Lexington, Kentucky. ERCP/EUS uses an endoscope which is a long flexible narrow tube with a camera at the end is passed through the mouth, esophagus, stomach and the first part of the duodenum. The goal is to access a small elevation in the duodenum called the papilla of Vater. This papilla drains the biliary and pancreatic ducts which brings digestive juices from the liver, gallbladder and the pancreas. The endoscopist will inject contrast dye through the papilla into the ducts and takes X-rays to show lesions such as stones, strictures or blockages. If appropriate these can be treated by passing instruments through a port in the endoscope. Immediately following the endoscopic intervention; complications (bleeding, aspiration, perforation) will be recorded by study personnel as either yes or no, which will be used to assess the overall success of the procedure.
Study NCT04876768 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Use of different concentrations of oxygen during ERCP
Description: The endoscopic intervention will be conducted in the endoscopy suite located at UK Albert B. Chandler Hospital in Lexington, Kentucky. ERCP/EUS uses an endoscope which is a long flexible narrow tube with a camera at the end is passed through the mouth, esophagus, stomach and the first part of the duodenum. The goal is to access a small elevation in the duodenum called the papilla of Vater. This papilla drains the biliary and pancreatic ducts which brings digestive juices from the liver, gallbladder and the pancreas. The endoscopist will inject contrast dye through the papilla into the ducts and takes X-rays to show lesions such as stones, strictures or blockages. If appropriate these can be treated by passing instruments through a port in the endoscope. Immediately following the endoscopic intervention; complications (bleeding, aspiration, perforation) will be recorded by study personnel as either yes or no, which will be used to assess the overall success of the procedure.
Study NCT05908578 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High Frequency Exercise Training
Description: Two sessions per week of high-intensity interval training (30 min each) and two sessions per week of continuous endurance exercise (30 min each). All exercise sessions will be performed on a stationary bike under supervision by an investigator.
Study NCT05908578 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Frequency Exercise Training
Description: One session per week of high-intensity interval training (60 min) and one session per week of continuous endurance exercise (60 min). All exercise sessions will be performed on a stationary bike under supervision by an investigator.
Study NCT05245305 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction Program
Description: The intervention was structured as 11 weeks, taking into account the group. The program takes 2-2.5 hours per week. The program includes raisin exercise, body scanning meditation, breath awareness meditation, sitting meditation, mindfull movement, walking meditation, vision meditation, compassion meditation,mindfulness communication and day of silence.
Study NCT05869110 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effects of odours on calorie intake, food choice and metabolic parameters
Description: Evaluation of the effects of olfactory stimulation compared to placebo on calorie intake and preference of food during a test-buffet.~Odours will be assigned in a randomized order. Each participant will receive both odours, in between there will be a wash-out period of 1 week.
Study NCT05869110 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Effects of odours on calorie intake, food choice and metabolic parameters
Description: Evaluation of the effects of olfactory stimulation compared to placebo on calorie intake and preference of food during a test-buffet.~Odours will be assigned in a randomized order. Each participant will receive both odours, in between there will be a wash-out period of 1 week.
Study NCT05076747 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardiovascular training
Description: 8 weeks of cardiovascular training
Study NCT05076747 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Therapy
Description: 8 weeks of Standard Therapy
Study NCT05590117 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pentoxifylline
Description: Pentoxifylline is a potent anti inflammatory may prevent chemotherapy induced neuropathy and mucositis and will be administered 400mg twice daily
Study NCT05590117 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo tablets
Study NCT05590117 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: FOLFOX-6 regimen
Description: 12 cycles of FOLFOX-6 regimen
Study NCT05590117 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FOLFOX-6 regimen
Description: 12 cycles of FOLFOX-6 regimen
Study NCT04785040 — intervention group
Intervention type: OTHER
Intervention: The groups evaluated by The Musculoskeletal Pain Intensity and Interference Questionnaire for Professional Orchestra Musicians, Brief Pain Inventory, QuickDASH and Fatigue Severity Scale
Description: The groups evaluated by The Musculoskeletal Pain Intensity and Interference Questionnaire for Professional Orchestra Musicians, Brief Pain Inventory, QuickDASH and Fatigue Severity Scale
Study NCT06528509 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AI-Generated Informative Videos
Description: Participants in the experimental arm will receive an AI-generated video designed to provide comprehensive information about cataract surgery. The video will cover key aspects of the procedure, including the nature of the surgery, potential risks, benefits, and postoperative care. The video will be produced in English for Cohort A, and translated into Bengali for Cohort B.~The video will be delivered to participants via a secure link sent to their mobile devices or email. Patients can watch the video at their convenience, and they are encouraged to view it as many times as necessary to fully understand the information provided. The video link will be provided once after the initial clinic appointment, but patients can access and watch the video multiple times.~The videos will be created using the Synthesia platform, which uses artificial intelligence to generate realistic, photo-realistic digital avatars that deliver the information in a personalized and engaging manner.
Study NCT06528509 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Written Information Brochures
Description: Participants in the control arm will receive traditional written information brochures about cataract surgery. These brochures are designed to deliver detailed and essential information in a clear and understandable format. The brochures will be handed to participants during their face-to-face clinic appointment. Patients can read the material at their convenience and keep it for future reference. These brochures follow standardized guidelines and recommendations to ensure that all relevant information is included and presented in an accessible manner. The leaflet will be supplied in English for Cohort A, and Bengali for Cohort B.
Study NCT05846217 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Multiwave Locked System
Description: Multiwave Locked System laser is a class IV NIR laser with two synchronized sources (905 nm with 75 W peak power, pulsed mode; 808 nm with power 1 W, continuous mode). Both laser beams were synchronized, the locked waves work with the range 1-2000 Hz.
Study NCT05846217 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multiwave Locked System
Description: Multiwave Locked System laser is a class IV NIR laser with two synchronized sources (905 nm with 75 W peak power, pulsed mode; 808 nm with power 1 W, continuous mode). Both laser beams were synchronized, the locked waves work with the range 1-2000 Hz.
Study NCT05587426 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: SFF
Description: Ingestion of 20g of SFF after 10-14 hours of fasting
Study NCT05587426 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Glucose
Description: Ingestion of 20g of glucose after 10-14 hours of fasting
Study NCT05587426 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: SFF chocolate chips
Description: Ingestion of 50g of chocolate chips made with SFF after 10-14 hours of fasting
Study NCT05587426 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Regular chocolate chips
Description: Ingestion of 50g of regular chocolate chips after 10-14 hours of fasting
Study NCT05922813 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BMI2004
Description: hyaluronidase, recombinant
Study NCT05922813 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% NaCl
Description: Normal Saline
Study NCT05688254 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FOREST-A
Description: The internet-based psychosocial intervention will be delivered. The intervention comprises six modules: introduction, relaxation, psychological detachment, mastery, control, and summary, within psychoeducation and exercises in each module. The interactions with psychologists will be on demand. The whole intervention duration will be 4 weeks.
Study NCT05221749 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nanosilver Fluoride (NSF)
Description: Optimized synthesis of Nanosilver Fluoride
Study NCT05221749 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Silver diamine fluoride
Description: Silver Diamine Fluoride
Study NCT06158828 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabbit Anti thymocyte globulin
Description: rATG is administered intravenously over 6-18 hours for a total of 2 to 3 doses. The daily dose is based on body weight and lymphocyte count.